Loading...
menu
Search
AI Trading Bot
Features
Markets
News
Resources
Pricing
Get Started
Home
ETF
TNYA
TNYA
-
Add to Watchlist
$
0.000
0.000
(
0.000%
)
At close
0.000
(
0.000%
)
Aft-market
ET
$
0.000
0.000
(
0.000%
)
At close
0.000
(
0.000%
)
Aft-market
ET
Overview
Technical
News
TNYA News
Tenaya Therapeutics Reports Q4 Results and Financing Update
Mar 11 2026
seekingalpha
Tenaya's TN-301 Outperforms Givinostat in DMD Cardiomyopathy
Mar 09 2026
Newsfilter
Tenaya Partners with Alnylam for Heart Drug Development
Mar 06 2026
stocktwits
Health Care Stocks Decline, NYSE Health Care Index Drops 2.3%
Mar 05 2026
Yahoo Finance
Tenaya Therapeutics Partners with Alnylam for Genetic Research
Mar 05 2026
Benzinga
Tenaya Therapeutics Partners with Alnylam for Up to $1.1B Cardiovascular Drug Collaboration
Mar 05 2026
seekingalpha
Tenaya and Alnylam Enter Research Collaboration Agreement
Mar 05 2026
NASDAQ.COM
Tenaya and Alnylam Forge Collaboration for Genetic Heart Disease Targets
Mar 05 2026
Newsfilter
Tenaya Therapeutics Plans 2026 Data Release for Heart Disease Gene Therapies
Jan 09 2026
Globenewswire
Tenaya Shares Drop Following $60 Million Equity Raise
Dec 12 2025
Benzinga
S&P 500 Declines 1%; Broadcom Reports Earnings Exceeding Expectations
Dec 12 2025
Benzinga
Dow Gains More Than 100 Points as Lululemon Reports Strong Q3 Earnings
Dec 12 2025
Benzinga
Tenaya Therapeutics Sets $60 Million Price for 50 Million Unit Offering, Clinical Hold on TN-201 Rescinded
Dec 12 2025
NASDAQ.COM
Tenaya Therapeutics Sets Price for $60 Million Unit Offering
Dec 12 2025
Yahoo Finance
Tenaya Therapeutics Prices $60 Million Public Offering
Dec 12 2025
Newsfilter
Tenaya Therapeutics Prices $60 Million Public Offering of 50 Million Units
Dec 12 2025
Globenewswire
Show More News
